Cytomegalovirus (CMV), Congenital, Qualitative PCR, Saliva Swab

CPT: 87496
Call client services.
87496
Updated on 08/21/2023
Print Share

Expected Turnaround Time

3 Days

3 Days


Specimen Requirements


Specimen

Saliva swab


Volume

1 swab


Minimum Volume

1 swab


Container

Universal Transport Media (UTM); Viral Transport Media (VTM), including UVT, MART, M4 and M6


Collection

A saliva swab should be collected at least one hour after breastfeeding. Insert a sterile polyester swab into the baby's mouth between the gum and cheek and swirl for several seconds. Remove the swab and place into the UTM or VTM container. Carefully break the swab at the score line and submit for testing.


Storage Instructions

Refrigerate.

Per package insert: Refrigerated swabs are stable for 7 days. Frozen swabs are stable for 14 days (-20°C).


Causes for Rejection

Saliva swabs not submitted in UTM or VTM; saliva swabs submitted in non-approved collection containers; e-swabs or other collection devices intended for bacterial culture; collection containers submitted without a swab; saliva swabs submitted from patients >21 days of age

Saliva swabs not submitted in UTM or VTM; saliva swabs submitted in non-approved collection containers; e-swabs or other collection devices intended for bacterial culture; collection containers submitted without a swab; saliva swabs submitted from patients >21 days of age

Saliva swabs not submitted in UTM or VTM; saliva swabs submitted in non-approved collection containers; e-swabs or other collection devices intended for bacterial culture; collection containers submitted without a swab; saliva swabs submitted from patients >21 days of age

Saliva swabs not submitted in UTM or VTM; saliva swabs submitted in non-approved collection containers; e-swabs or other collection devices intended for bacterial culture; collection containers submitted without a swab; saliva swabs submitted from patients >21 days of age

Saliva swabs not submitted in UTM or VTM; saliva swabs submitted in non-approved collection containers; e-swabs or other collection devices intended for bacterial culture; collection containers submitted without a swab; saliva swabs submitted from patients >21 days of age


Test Details


Use

This test is intended for the in vitro qualitative detection of cytomegalovirus (CMV) DNA from salvia swabs collected in universal transport (UTM) or viral transport media (VTM) from infants <21 days of age. Results from this assay should be used in conjunction with the results of other clinical findings as an aid in the diagnosis of congenital CMV infection. Positive results from a saliva swab are presumptive and should be confirmed with urine.

This test is intended for the in vitro qualitative detection of cytomegalovirus (CMV) DNA from salvia swabs collected in universal transport (UTM) or viral transport media (VTM) from infants <21 days of age. Results from this assay should be used in conjuhction with the results of other clinical findings as an aid in the diagnosis of congenital CMV infection. Positive results from a saliva swab are presumptive and should be confirmed with urine.

This test is intended for the in vitro qualitative detection of cytomegalovirus (CMV) DNA from salvia swabs collected in universal transport (UTM) or viral transport media (VTM) from infants <21 days of age. Results from this assay should be used in conjunction with the results of other clinical findings as an aid in the diagnosis of congenital CMV infection. Positive results from a saliva swab are presumptive and should be confirmed with urine.


Limitations

Results from this test must be considered in conjunction with clinical history, epidemiological data and other laboratory information available to the clinician evaluating the patient.

The detection of viral nucleic acid is dependent on proper sample collection, transport, handling, storage and preparation. Failure to observe proper procedures in any of these steps can lead to incorrect results.

Negative results do not rule out congenital CMV infections and should not be used as the sole basis for treatment or other patient management decisions.

False negative results may occur if the viruses are present at a level that is below the analytical sensitivity of the assay or if the virus has mutations, insertions, deletions or rearrangements.

The prevalence of viral infections may affect the test's predictive value. As with other tests, false positive may occur.

Positive results from saliva swab screening for congenital CMV infection are considered presumptively positive and should be confirmed with detection of CMV in a urine sample.

Results from this test must be considered in conjunction with clinical history, epidemiological data and other laboratory information available to the clinician evaluating the patient.

The detection of viral nucleic acid is dependent on proper sample collection, transport, handling, storage and preparation. Failure to observe proper procedures in any of these steps can lead to incorrect results.

Negative results do not rule out congenital CMV infections and should not be used as the sole basis for treatment or other patient management decisions.

False negative results may occur if the viruses are present at a level that is below the analtical sensitivity of the assay or if the virus has mutations, inserions, deletions or rearrangements.

The prevalence of viral infections may affect the test's predictive value. As with other tests, false positive may occur.

Positive results from saliva swab screening for congenital CMV infection are considered presumptively positive and should be confirmed with detection of CMV in a urine sample.

Results from this test must be considered in conjunction with clinical history, epidemiological data and other laboratory information available to the clinician evaluating the patient.

The detection of viral nucleic acid is dependent on proper sample collection, transport, handling, storage and preparation. Failure to observe proper procedures in any of these steps can lead to incorrect results.

Negative results do not rule out congenital CMV infections and should not be used as the sole basis for treatment or other patient management decisions.

False negative results may occur if the viruses are present at a level that is below the analytical sensitivity of the assay or if the virus has mutations, insertions, deletions or rearrangements.

The prevalence of viral infections may affect the test's predictive value. As with other tests, false positive may occur.

Positive results from saliva swab screening for congenital CMV infection are considered presumptively positive and should be confirmed with detection of CMV in a urine sample.


Methodology

Polymerase chain reaction (PCR)


LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
139865 Congenital CMV PCR Saliva Swab 83065-3 139866 Cytomegalovirus (CMV), DNA 83065-3

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf